| pubmed-article:12074781 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12074781 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:12074781 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12074781 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12074781 | lifeskim:mentions | umls-concept:C0085957 | lld:lifeskim |
| pubmed-article:12074781 | lifeskim:mentions | umls-concept:C0005682 | lld:lifeskim |
| pubmed-article:12074781 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
| pubmed-article:12074781 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:12074781 | lifeskim:mentions | umls-concept:C0442124 | lld:lifeskim |
| pubmed-article:12074781 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:12074781 | pubmed:dateCreated | 2002-6-20 | lld:pubmed |
| pubmed-article:12074781 | pubmed:abstractText | To study the clinical and pathological factors that affect recurrence, progression and survival in pT1G3 bladder tumours treated conservatively. | lld:pubmed |
| pubmed-article:12074781 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12074781 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12074781 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12074781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12074781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12074781 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12074781 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:12074781 | pubmed:issn | 0302-2838 | lld:pubmed |
| pubmed-article:12074781 | pubmed:author | pubmed-author:PatardJean-Ja... | lld:pubmed |
| pubmed-article:12074781 | pubmed:author | pubmed-author:Rioux-Leclerc... | lld:pubmed |
| pubmed-article:12074781 | pubmed:author | pubmed-author:LobelBernardB | lld:pubmed |
| pubmed-article:12074781 | pubmed:author | pubmed-author:RodriguezAlej... | lld:pubmed |
| pubmed-article:12074781 | pubmed:author | pubmed-author:LerayEmmanuel... | lld:pubmed |
| pubmed-article:12074781 | pubmed:author | pubmed-author:GuilléFrançoi... | lld:pubmed |
| pubmed-article:12074781 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12074781 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:12074781 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12074781 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12074781 | pubmed:pagination | 635-41; discussion 642 | lld:pubmed |
| pubmed-article:12074781 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:meshHeading | pubmed-meshheading:12074781... | lld:pubmed |
| pubmed-article:12074781 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12074781 | pubmed:articleTitle | Intravesical Bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours. | lld:pubmed |
| pubmed-article:12074781 | pubmed:affiliation | Department of Urology, CHU, Rennes, France. jean-jacques.patard@chu-rennes.fr | lld:pubmed |
| pubmed-article:12074781 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12074781 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12074781 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12074781 | lld:pubmed |
